eicosapentaenoic acid ethyl ester has been researched along with Syndrome in 1 studies
Syndrome: A characteristic symptom complex.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krznaric, Ž | 1 |
| Juretic, A | 1 |
| Domislovic, V | 1 |
| Barisic, A | 1 |
| Kekez, D | 1 |
| Vranesic Bender, D | 1 |
1 other study available for eicosapentaenoic acid ethyl ester and Syndrome
| Article | Year |
|---|---|
Ten years of Croatian national guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome - Evaluation of awareness and implementation among Croatian oncologists.
Topics: Cachexia; Eicosapentaenoic Acid; Humans; Megestrol Acetate; Neoplasms; Nutritional Support; Oncologi | 2019 |